Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

被引：2
|
作者：
Coombes, Ian D. [1 ,2 ,3 ]
Legg, Amy [1 ,3 ,4 ,6 ]
Patterson, Tina [3 ,5 ,6 ]
Kelly, Tanya [3 ,7 ,8 ]
Henderson, Andrew [3 ,5 ,9 ]
Roberts, Jason A. [1 ,3 ,4 ,10 ,11 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
[2] Univ Queensland, Dept Pharm, Brisbane, Qld, Australia
[3] COVID 19 Med Pharm Planning & Response Grp, Brisbane, Qld, Australia
[4] Metro North Hlth, Herston Infect Dis Inst HeIDI, Brisbane, Qld, Australia
[5] COVID 19 Clin Therapeut Guideline Working Grp, Brisbane, Qld, Australia
[6] Logan Hosp, Dept Pharm, Brisbane, Qld, Australia
[7] Sunshine Coast Univ Hosp, Dept Anaesthesia & Perioperat Med, Sunshine Coast, Qld, Australia
[8] Queensland Clin Senate, Clin Excellence Queensland, Brisbane, Qld, Australia
[9] Princess Alexandra Hosp, Dept Infect Dis, Brisbane, Qld, Australia
[10] Univ Queensland, Fac Med, Ctr Clin Res, Brisbane, Qld, Australia
[11] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
来源：
AUSTRALIAN PRESCRIBER | 2022年 / 45卷 / 02期
关键词：
COVID-19; molnupiravir; nirmatrelvir/ritonavir; quality use of medicines; SARS-CoV-2;
D O I：
10.18773/austprescr.2022.021
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] Corticosteroids prescription for mild-moderate COVID-19 in Primary Care
    Ordinola Navarro, Alberto
    Lopez Luis, Bruno Ali
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (12): : 1813 - 1815
  • [2] Antivirals for the treatment of mild and moderate COVID-19 in South Africa
    Perumal, R.
    Naidoo, V.
    Govender, S.
    Gengiah, T. N.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2023, 113 (12): : 1535 - 1543
  • [3] Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia
    Ozdemir, Yusuf Emre
    Balkan, Ilker Inanc
    Bayramlar, Osman Faruk
    Alkan, Sena
    Murt, Ahmet
    Karaali, Ridvan
    Mete, Bilgul
    Kuskucu, Mert Ahmet
    Aygun, Gokhan
    Keskindemirci, Yilmaz
    Ongoren, Seniz
    Kutlubay, Zekayi
    Cetinkale, Oguz
    Saltoglu, Nese
    Tabak, Fehmi
    [J]. MIKROBIYOLOJI BULTENI, 2021, 55 (03): : 342 - 356
  • [4] Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19
    Knox, Hannah B.
    Dykes, Lisa A.
    Scott, Lancer A.
    Presley, Bradley C.
    Lambert, Lara C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 985 - 993
  • [5] Prediction of the Rehabilitation Duration and Risk Management for Mild-Moderate COVID-19
    Zheng, Qiong-Na
    Xu, Mei-Yan
    Zheng, Yong-Le
    Wang, Xiu-Ying
    Zhao, Hui
    [J]. DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2020, 14 (05) : 652 - 657
  • [6] Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador
    Checa, Alejandro
    Navas, Eliana
    Valencia, Veronica
    Alcivar, Jessica
    [J]. REVISTA MEXICANA DE NEUROCIENCIA, 2022, 23 (04): : 126 - 129
  • [7] Artificial intelligence for diagnosis of mild-moderate COVID-19 using haematological markers
    Chadaga, Krishnaraj
    Prabhu, Srikanth
    Bhat, Vivekananda
    Sampathila, Niranjana
    Umakanth, Shashikiran
    Chadaga, Rajagopala
    [J]. ANNALS OF MEDICINE, 2023, 55 (01)
  • [8] EARLY REMDESIVIR FOR VACCINATED KIDNEY TRANSPLANT RECIPIENTS WITH MILD-MODERATE COVID-19 INFECTION
    Hirsch, Daniel
    Sivanathan, Vithoo
    Agnew, Eleanor
    Kuhasri, Abidev
    Lee, Vivian
    Mcginn, Stella
    Li, Yan
    [J]. NEPHROLOGY, 2023, 28 : 57 - 58
  • [9] Decreased quality of life and spirometric alterations even after mild-moderate COVID-19
    Navarro, Alberto Ordinola
    Cervantes-Bojalil, Javier
    Cobos Quevedo, Orestes de Jesus
    Avila Martinez, Andrea
    Alberto Hernandez-Jimenez, Carlos
    Perez Alvarez, Esperanza
    Gonzalez Gil, Andrea
    Peralta Amaro, Ana Lilia
    Vera-Lastra, Olga
    Lopez Luis, Bruno Ali
    [J]. RESPIRATORY MEDICINE, 2021, 181
  • [10] Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
    Adam K. Wheatley
    Jennifer A. Juno
    Jing J. Wang
    Kevin J. Selva
    Arnold Reynaldi
    Hyon-Xhi Tan
    Wen Shi Lee
    Kathleen M. Wragg
    Hannah G. Kelly
    Robyn Esterbauer
    Samantha K. Davis
    Helen E. Kent
    Francesca L. Mordant
    Timothy E. Schlub
    David L. Gordon
    David S. Khoury
    Kanta Subbarao
    Deborah Cromer
    Tom P. Gordon
    Amy W. Chung
    Miles P. Davenport
    Stephen J. Kent
    [J]. Nature Communications, 12
12345